Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin

ClinicalTrials.gov ID: NCT01376557

Public ClinicalTrials.gov record NCT01376557. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of LX4211 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Monotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is intended to assess the effect on HbA1c of different dose regimens of LX4211 in combination with metformin in subjects with Type 2 Diabetes Mellitus who have inadequate glycemic control on metformin monotherapy.

Study identification

NCT ID
NCT01376557
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Lexicon Pharmaceuticals
Industry
Enrollment
299 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2011
Primary completion
Apr 30, 2012
Completion
Apr 30, 2012
Last update posted
Oct 30, 2014

2011 – 2012

United States locations

U.S. sites
56
U.S. states
25
U.S. cities
51
Facility City State ZIP Site status
Lexicon Investigational Site Anaheim California 92801
Lexicon Investigational Site Carmichael California 95608
Lexicon Investigational Site Greenbrae California 94904
Lexicon Investigational Site La Jolla California 92037
Lexicon Investigational Site Northridge California 91325
Lexicon Investigational Site Orange California 92868
Lexicon Investigational Site Pismo Beach California 93449
Lexicon Investigational Site Tarzana California 91356
Lexicon Investigational Site Tustin California 92780
Lexicon Investigational Site Denver Colorado 80209
Lexicon Investigational Site Denver Colorado 80220
Lexicon Investigational Site Newark Delaware 19713
Lexicon Investigational Site Edgewater Florida 32132
Lexicon Investigational Site Miami Florida 33135
Lexicon Investigational Site Orlando Florida 32806
Lexicon Investigational Site West Palm Beach Florida 33401
Lexicon Investigational Site Winter Park Florida 32792
Lexicon Investigational Site Blue Ridge Georgia 30513
Lexicon Investigational Site Savannah Georgia 31406
Lexicon Investigational Site Lafayette Indiana 47904
Lexicon Investigational Site Madisonville Kentucky 42431
Lexicon Investigational Site Baton Rouge Louisiana 70808
Lexicon Investigational Site Brockton Massachusetts 02301
Lexicon Investigational Site Waltham Massachusetts 02453
Lexicon Investigational Site Traverse City Michigan 49684
Lexicon Investigational Site Olive Branch Mississippi 38654
Lexicon Investigational Site Kansas City Missouri 64111
Lexicon Investigational Site Omaha Nebraska 68131
Lexicon Investigational Site Las Vegas Nevada 89101
Lexicon Investigational Site Las Vegas Nevada 89128
Lexicon Investigational Site Great Neck New York 11023
Lexicon Investigational Site West Seneca New York 14224
Lexicon Investigational Site Greensboro North Carolina 27455
Lexicon Investigational Site Winston-Salem North Carolina 27103
Lexicon Investigational Site Grand Forks North Dakota 58201
Lexicon Investigational Site Canal Fulton Ohio 44614
Lexicon Investigational Site Dayton Ohio 45439
Lexicon Investigational Site Kettering Ohio 45429
Lexicon Investigational Site Perrysburg Ohio 43551
Lexicon Investigational Site Eugene Oregon 97404
Lexicon Investigational Site Uniontown Pennsylvania 15401
Lexicon Investigational Site Clinton South Carolina 29325
Lexicon Investigational Site Mt. Pleasant South Carolina 29464
Lexicon Investigational Site Chattanooga Tennessee 37411
Lexicon Investigational Site Chattanooga Tennessee 37421
Lexicon Investigational Site Austin Texas 78728
Lexicon Investigational Site Dallas Texas 75230
Lexicon Investigational Site Houston Texas 77024
Lexicon Investigational Site Houston Texas 77098
Lexicon Investigational Site Killeen Texas 76543
Lexicon Investigational Site San Antonio Texas 78229
Lexicon Investigational Site San Antonio Texas 78258
Lexicon Investigational Site Tomball Texas 77375
Lexicon Investigational Site Ogden Utah 84403
Lexicon Investigational Site Salt Lake City Utah 84109
Lexicon Investigational Site Virginia Beach Virginia 23454

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01376557, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 30, 2014 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01376557 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →